{"id":"https://openalex.org/W2990172087","doi":null,"title":"[Quality of life, in depressed patients in Primary Health Care setting. Effectiveness and safety of venlafaxine extended release].","display_name":"[Quality of life, in depressed patients in Primary Health Care setting. Effectiveness and safety of venlafaxine extended release].","publication_year":2003,"publication_date":"2003-11-01","ids":{"openalex":"https://openalex.org/W2990172087","mag":"2990172087","pmid":"https://pubmed.ncbi.nlm.nih.gov/14639509"},"language":"es","primary_location":{"id":"pmh:oai:actaspsiquiatria.es:article/1203","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/1203","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/1203/1954","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://actaspsiquiatria.es/index.php/actas/article/download/1203/1954","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078510198","display_name":"Enrique Baca Baldomero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105637","display_name":"Hospital Universitario Puerta de Hierro Majadahonda","ror":"https://ror.org/01e57nb43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210105637","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E Baca Baldomero","raw_affiliation_strings":["Hospital Universitario Puerta de Hierro, Madrid, Spain. ebaca@mi.madritel.es","Hospital Universitario Puerta de Hierro, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Puerta de Hierro, Madrid, Spain. ebaca@mi.madritel.es","institution_ids":["https://openalex.org/I4210105637"]},{"raw_affiliation_string":"Hospital Universitario Puerta de Hierro, Madrid, Spain","institution_ids":["https://openalex.org/I4210105637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074482765","display_name":"Salvador Cervera Enguix","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Cervera Enguix","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.41438814,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"6","first_page":"331","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine-extended-release","display_name":"venlafaxine extended release","score":0.996999979019165},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.843999981880188},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9480000138282776},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.8339999914169312},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8059999942779541},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7900000214576721},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8659999966621399},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.8759999871253967},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.91853928565979},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.8328976035118103},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6996679902076721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6606982946395874},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5810523629188538},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5723472237586975},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.519971489906311},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5091390013694763},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.490730881690979},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4473096430301666},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.42376330494880676},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3437052369117737},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.24815234541893005},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008605","descriptor_name":"Mental Health Services","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmh:oai:actaspsiquiatria.es:article/1203","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/1203","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/1203/1954","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:14639509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14639509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas espanolas de psiquiatria","raw_type":"Clinical Trial"},{"id":"mag:2990172087","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14639509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:actaspsiquiatria.es:article/1203","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/1203","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/1203/1954","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2990172087.pdf","grobid_xml":"https://content.openalex.org/works/W2990172087.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7218210516","https://openalex.org/W2162911770","https://openalex.org/W2141185147","https://openalex.org/W2983107733","https://openalex.org/W7217042668","https://openalex.org/W1561304003","https://openalex.org/W1968027757","https://openalex.org/W74728205","https://openalex.org/W1986715244","https://openalex.org/W2069851433"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1],"aim":[2],"of":[3,16,18,27,59,65,79,84,104,109,122,154,157,166,212,221],"this":[4],"observational":[5],"study":[6],"was":[7,96,184],"to":[8,29,130,151],"evaluate":[9],"effectiveness,":[10],"tolerability":[11],"and":[12,56,102,134,142,162,176,205,217],"impact":[13],"on":[14,179],"quality":[15,103,220],"life":[17,105],"treatment":[19],"with":[20,61,67,106],"venlafaxine":[21,85],"extended":[22,86,200],"release":[23,87,201],"at":[24],"a":[25,68,128,138,203],"dose":[26],"75":[28,80],"150":[30,82],"mg/day,":[31],"in":[32,36,111,127,137],"depressed":[33],"outpatients":[34],"treated":[35],"Primary":[37,49,213],"Health":[38,50,214],"Care.":[39],"METHODS:":[40],"Observational,":[41],"prospective,":[42],"open-labeled":[43],"study,":[44],"carried":[45],"out":[46],"by":[47],"882":[48],"Care":[51,215],"physicians.":[52],"Outpatients,":[53],"between":[54],"18":[55],"70":[57],"years":[58],"age":[60],"depressive":[62,210],"symptomatology":[63],"susceptible":[64],"treatment,":[66],"Hamilton":[69],"Depression":[70,112],"Scale":[71,113],"(HAM-D17)":[72],"score":[73,145],"14":[74],"were":[75,88,120,125,160],"included.":[76],"Daily":[77],"doses":[78],"or":[81,173,187],"mg":[83],"administered":[89],"orally":[90],"for":[91,189],"24":[92],"weeks.":[93],"Antidepressant":[94],"effectiveness":[95,132],"assessed":[97],"using":[98],"the":[99,107,152,158,167,180],"HAM-D17":[100,141],"scale":[101],"Quality":[108],"Life":[110],"(QLDS),":[114],"Spanish":[115],"version.":[116],"RESULTS:":[117],"4,747":[118],"patients":[119,136,159,193,216],"recruited,":[121],"which":[123],"4,320":[124],"included":[126],"intention":[129],"treat":[131],"analysis":[133],"4,557":[135],"safety":[139],"analysis.":[140],"QLDS":[143],"mean":[144],"significantly":[146],"decreased":[147],"from":[148],"week":[149],"4":[150],"end":[153],"study.":[155],"86,2%":[156],"responders":[161],"73.8%":[163],"achieved":[164],"remission":[165],"symptoms.":[168],"Likewise,":[169],"95%":[170],"reported":[171,195],"absence":[172],"mild":[174],"somatic":[175],"psychic":[177],"anxiety":[178],"final":[181],"visit.":[182],"Tolerability":[183],"considered":[185],"good":[186],"excellent":[188],"98.7%":[190],"subjects.":[191],"191":[192],"(4.2%)":[194],"adverse":[196],"events.":[197],"CONCLUSIONS:":[198],"Venlafaxine":[199],"is":[202],"safe":[204],"effective":[206],"drug":[207],"that":[208],"reduces":[209],"symptoms":[211],"improves":[218],"their":[219],"life.":[222]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-12-05T00:00:00"}